Clinical trial
Olmesartan Pediatric Pharmacokinetic (PK) Study
NCT00151814 · Daiichi Sankyo, Industry · Completed
Key facts
| NCT number | NCT00151814 |
|---|---|
| Title | Olmesartan Pediatric Pharmacokinetic (PK) Study |
| Official title | An Open-label Study of the Single-dose Pharmacokinetics of Olmesartan Medoxomil in Pediatric Patients With Hypertension |
| Lead sponsor | Daiichi Sankyo, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Hypertension |
| Intervention type | Drug |
| Interventions | Olmesartan medoxomil |
| Enrollment | 24 |
| Start date | Sep 1, 2005 |
| Primary completion | Feb 1, 2008 |
| Completion | Feb 1, 2008 |
| First posted | Sep 9, 2005 |
| Last update posted | Apr 15, 2010 |
| Countries | United States |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: